참고문헌 (35)

1. 1 Räth K , Taxis K , Walz G , Gleiter CH , Li SM , Heide L : Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L . (annual wormwood) . Am J Trop Med Hyg 2004 ; 70 : 128 – 132 14993622 

2. 2 Ho WE , Peh HY , Chan TK , Wong WS : Artemisinins: Pharmacological actions beyond anti-malarial . Pharmacol Ther 2014 ; 142 : 126 – 139 24316259 

   상세보기

3. 3 Kim MH , Seo JY , Liu KH , Kim JS : Protective effect of Artemisia annua L. extract against galactose-induced oxidative stress in mice . PLoS One 2014 ; 9 : e101486 24988450 

4. 4 Zheng GQ : Cytotoxic terpenoids and flavonoids from Artemisia annua . Planta Med 1994 ; 60 : 54 – 57 8134418 

   상세보기

5. 5 Sun B , Karin M : Obesity, inflammation, and liver cancer . J Hepatol 2012 ; 56 : 704 – 713 22120206 

   상세보기

6. 6 Postic C , Girard J : The role of the lipogenic pathway in the development of hepatic steatosis . Diabetes Metab 2008 ; 34 : 643 – 648 19195625 

7. 7 Abelmalek MF , Diehl AM : Nonalcoholic fatty liver disease as a complication of insulin resistance . Med Clin North Am 2007 ; 91 : 1125 – 1149 17964913 

   상세보기

8. 8 Tu K , Zheng X , Yin G , Zan X , Yao Y , Liu Q : Evaluation of Fbxw7 expression and its correlation with expression of SREBP-1 in a mouse model of NAFLD . Mol Med Rep 2012 ; 6 : 525 – 530 22710480 

9. 9 Dentin R , Girard J , Postic C : Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): Two key regulators of glucose metabolism and lipid synthesis in liver . Biochimie 2005 ; 87 : 81 – 86 15733741 

   상세보기

10. 10 Filhoulaud G , Guilmeau S , Dentin R , Girard J , Postic C : Novel insights into ChREBP regulation and function . Trends Endocrinol Metab 2013 ; 24 : 257 – 268 23597489 

    상세보기

11. 11 Foufelle F , Ferré P : New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: A role for the transcription factor sterol regulatory element binding protein-1c . Biochem J 2002 ; 366 : 377 – 391 12061893 

    상세보기

12. 12 Kamari Y , Shaish A , Vax E , et al. : Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice . J Hepatol 2011 ; 55 : 1086 – 1094 21354232 

    상세보기

13. 13 Chen R , Hou W , Zhang Q , Kang R , Fan XG , Tang D : Emerging role of high-mobility group box 1 (HMGB1) in liver diseases . Mol Med 2013 ; 19 : 357 – 366 24306421 

    상세보기

14. 14 Chiang DJ , Pritchard MT , Nagy LE : Obesity, diabetes mellitus, and liver fibrosis . Am J Physiol Gastrointest Liver Physiol 2011 ; 300 : G697 – G702 21350183 

15. 15 Matsui T , Ueda T , Oki T , Sugita K , Terahara N , Matsumoto K : α-Glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity . J Agric Food Chem 2001 ; 49 : 1948 – 1951 11308351 

    상세보기

16. 16 Jeon BT , Heo RW , Shin HJ , et al. : Attenuation by a Vigna nakashimae extract of nonalcoholic fatty liver disease in high-fat diet-fed mice . Biosci Biotechnol Biochem 2014 ; 78 : 482 – 489 25036839 

    상세보기

17. 17 Alexei L , Eba A , Benhilda NM , et al. : Integrating medicinal plants extraction into a high-value biorefinery: An example of Artemisia annua L . C R Chim 2014 ; 17 : 232 – 241 

18. 18 Choi HN , Kang MJ , Lee SJ , Kim JI : Ameliorative effect of myricetin on insulin resistance in mice fed a high-fat, high-sucrose diet . Nutr Res Pract 2014 ; 8 : 544 – 549 25324935 

    원문보기 상세보기

19. 19 Huang GJ , Hsieh WT , Chang HY , Huang SS , Lin YC , Kuo YH : α-Glucosidase and aldose reductase inhibitory activities from the fruiting body of Phellinus merrillii . J Agric Food Chem 2011 ; 59 : 5702 – 5706 21452825 

    상세보기

20. 20 Kumar S , Narwal S , Kumar V , Prakash O : α-Glucosidase inhibitors from plants: A natural approach to treat diabetes . Pharmacogn Rev 2011 ; 5 : 19 – 29 22096315 

    상세보기

21. 21 Willcox ML , Burton S , Oyweka R , Namyalo R , Challand S , Lindsey K : Evaluation and pharmacovigilance of projects promoting cultivation and local use of Artemisia annua for malaria . Malar J 2011 ; 10 : 84 21481234 

    상세보기

22. 22 Wellen KE , Hotamisligil GS : Inflammation, stress, and diabetes . J Clin Invest 2005 ; 115 : 1111 – 1119 15864338 

    상세보기

23. 23 Liu IM , Tzeng TF , Liou SS , Lan TW : Improvement of insulin sensitivity in obese Zucker rats by myricetin extracted from Abelmoschus moschatus . Planta Med 2007 ; 73 : 1054 – 1060 17694473 

    상세보기

24. 24 Chang CJ , Tzeng TF , Liou SS , Chang YS , Liu IM : Myricetin increases hepatic peroxisome proliferator-activated receptor α protein expression and decreases plasma lipids and adiposity in rats . Evid Based Complement Alternat Med 2012 ; 2012 : 787152 22474525 

25. 25 Sakurai M , Takamura T , Ota T , et al. : Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease . J Gastroenterol 2007 ; 42 : 312 – 317 17464461 

26. 26 Ferré P , Foufelle F : Hepatic steatosis: A role for de novo lipogenesis and the transcription factor SREBP-1c . Diabetes Obes Metab 2010 ; 12 : 83 – 92 21029304 

    상세보기

27. 27 Iizuka K , Bruick RK , Liang G , Horton JD , Uyeda K : Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis . Proc Natl Acad Sci USA 2004 ; 101 : 7281 – 7286 15118080 

    상세보기

28. 28 Tsatsos NG , Davies MN , O'Callaghan BL , Towle HC : Identification and function of phosphorylation in the glucose-regulated transcription factor ChREBP . Biochem J 2008 ; 411 : 261 – 270 18215143 

    상세보기

29. 29 Dentin R , Benhamed F , Hainaylt , et al. : Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice . Diabetes 2006 ; 55 : 2159 – 2170 16873678 

    상세보기

30. 30 Iizuka K , Miller B , Uyeda K : Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice . Am J Physiol Endocrinol Metab 2006 ; 291 : E358 – E364 16705063 

31. 31 Benhamed F , Denechaud PD , Lemoine M , et al. : The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans . J Clin Invest 2012 ; 122 : 2176 – 2194 22546860 

    상세보기

32. 32 Ge WS , Wu JX , Fan JG , Wang YJ , Chen YW : Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells . World J. Gastroenterol 2011 ; 17 : 4090 – 4098 22039322 

33. 33 Chen J , Liu D , Bai Q , et al. : Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats . Mol Med Rep 2011 ; 4 : 811 – 816 21643627 

34. 34 Hsieh PS , Jin JS , Chiang CF , Chan PC , Chen CH , Shih KC : COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver . Obesity (Silver Spring) 2009 ; 17 : 1150 – 1157 19247274 

35. 35 Lipson KE , Wong C , Teng Y , Spong S : CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis . Fibrogenesis Tissue Repair 2012 ; 5 : S24 23259531